Representing Victims of Trasylol Side Effects
On November 5, 2007 Bayer AG announced they were removing their blood clotting drug Trasylol (aprotinin) from the market worldwide. While Bayer said the recall was not yet permanent, it is the first time the company publically acknowledged that the drug may be dangerous. Bayer AG said they decided to remove Trasylol from the market after a Canadian study revealed that the drug increased the risk of kidney damage, heart attack, stroke and death and was not more effective than competing medications. However, this recently released study was not the first study that clearly illustrated the risks of Trasylol. In January 2006 a prominent medical journal published the results of two older studies which both showed the dangers or Trasylol. One of these studies was an internal Bayer AG study that was not presented to the FDA.
Trasylol was originally approved by the FDA in 1993 for use in cardiac surgeries that typically required blood transfusions. The drug was designed to help the blood clot more quickly which would reduce or prevent the need for blood transfusions during common cardiac surgeries like bypass surgery. However, when the drug was approved the FDA was not aware of the potential side effects that the drug could cause. Today there are several safer alternatives to Trasylol which are also significantly less expensive.
Trasylol Side Effects/Injuries
- Kidney Damage
- Heart Attack
- Stroke
- Death
How do I know if Trasylol was used in my surgery?
Since Trasylol is administered during heart surgery most patients have no idea if the drug was given to them. If you had heart bypass surgery or any other cardiac surgery and you have experienced kidney damage, stroke or heart attack you should find out if you were given Trasylol. All medications given to you during surgery should be listed in your medical records. You can request these yourself or contact Mark & Associates, P.C. and we can obtain them for you.
Do I have Legal Rights?
If your or a loved one was given Trasylol and experienced kidney damage, heart attack, stroke or other injuries you may be entitled to compensation. Mark & Associates, P.C. is representing Trasylol injury victims on a contigency basis; this means there are no up front legal fees and we only receive compensation if we recover money on your behalf. For a free legal case consultation contact Mark & Associates, P.C. today by completing a case evaluation form or by calling 1-866-50-RIGHTS (1-866-507-4448).
Topic Video
Topic Quick Look
What are the risks?
Bayer AG announced it would stop selling Trasylol after a study linked the product to a 50 percent higher risk of death than competing drugs in patients undergoing heart surgery. However, Bayer did not commit to keeping the drug off the market permanently. The company said the medicine will be kept off the market worldwide for two months or more so results from the test can be examined.
Preemption and the FDA